DE69022046D1 - Verbesserungen im stimulierungsmittelbereich. - Google Patents
Verbesserungen im stimulierungsmittelbereich.Info
- Publication number
- DE69022046D1 DE69022046D1 DE69022046T DE69022046T DE69022046D1 DE 69022046 D1 DE69022046 D1 DE 69022046D1 DE 69022046 T DE69022046 T DE 69022046T DE 69022046 T DE69022046 T DE 69022046T DE 69022046 D1 DE69022046 D1 DE 69022046D1
- Authority
- DE
- Germany
- Prior art keywords
- enhancer
- pct
- novel
- locus
- sec
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/30—Vector systems having a special element relevant for transcription being an enhancer not forming part of the promoter region
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/60—Vector systems having a special element relevant for transcription from viruses
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Finger-Pressure Massage (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898909218A GB8909218D0 (en) | 1989-04-22 | 1989-04-22 | Improvements in or relating to enhancers |
PCT/GB1990/000604 WO1990012878A1 (en) | 1989-04-22 | 1990-04-20 | Improvements in or relating to enhancers |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69022046D1 true DE69022046D1 (de) | 1995-10-05 |
DE69022046T2 DE69022046T2 (de) | 1996-02-29 |
Family
ID=10655561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69022046T Expired - Fee Related DE69022046T2 (de) | 1989-04-22 | 1990-04-20 | Verbesserungen im stimulierungsmittelbereich. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5371009A (de) |
EP (1) | EP0469025B1 (de) |
JP (1) | JP3102697B2 (de) |
AT (1) | ATE127155T1 (de) |
AU (1) | AU5443890A (de) |
DE (1) | DE69022046T2 (de) |
GB (1) | GB8909218D0 (de) |
WO (1) | WO1990012878A1 (de) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6048729A (en) | 1987-05-01 | 2000-04-11 | Transkaryotic Therapies, Inc. | In vivo protein production and delivery system for gene therapy |
US5814318A (en) * | 1990-08-29 | 1998-09-29 | Genpharm International Inc. | Transgenic non-human animals for producing heterologous antibodies |
US6300129B1 (en) | 1990-08-29 | 2001-10-09 | Genpharm International | Transgenic non-human animals for producing heterologous antibodies |
US5545806A (en) * | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
US5770429A (en) * | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US5625126A (en) * | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
US7041871B1 (en) | 1995-10-10 | 2006-05-09 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US5633425A (en) * | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US5661016A (en) * | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
US7084260B1 (en) | 1996-10-10 | 2006-08-01 | Genpharm International, Inc. | High affinity human antibodies and human antibodies against human antigens |
US5877397A (en) * | 1990-08-29 | 1999-03-02 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
DE69133476T2 (de) * | 1990-08-29 | 2006-01-05 | GenPharm International, Inc., Palo Alto | Transgene Mäuse fähig zur Produktion heterologer Antikörper |
US5874299A (en) * | 1990-08-29 | 1999-02-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
NZ245015A (en) | 1991-11-05 | 1995-12-21 | Transkaryotic Therapies Inc | Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production |
US6054288A (en) * | 1991-11-05 | 2000-04-25 | Transkaryotic Therapies, Inc. | In vivo protein production and delivery system for gene therapy |
US6692737B1 (en) | 1991-11-05 | 2004-02-17 | Transkaryotic Therapies, Inc. | In vivo protein production and delivery system for gene therapy |
US6063630A (en) | 1991-11-05 | 2000-05-16 | Transkaryotic Therapies, Inc. | Targeted introduction of DNA into primary or secondary cells and their use for gene therapy |
US5858784A (en) * | 1991-12-17 | 1999-01-12 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol- and liposome-based delivery |
US5756353A (en) * | 1991-12-17 | 1998-05-26 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol-and liposome-based delivery |
US6627615B1 (en) | 1991-12-17 | 2003-09-30 | The Regents Of The University Of California | Methods and compositions for in vivo gene therapy |
US6806084B1 (en) | 1992-06-04 | 2004-10-19 | The Regents Of The University Of California | Methods for compositions for in vivo gene delivery |
IL105914A0 (en) * | 1992-06-04 | 1993-10-20 | Univ California | Methods and compositions for in vivo gene therapy |
US6531124B1 (en) | 1992-07-10 | 2003-03-11 | Transkaryotic Therapies, Inc. | In vivo production and delivery of insulinotropin for gene therapy |
US6670178B1 (en) | 1992-07-10 | 2003-12-30 | Transkaryotic Therapies, Inc. | In Vivo production and delivery of insulinotropin for gene therapy |
JP3415840B2 (ja) * | 1992-11-28 | 2003-06-09 | 財団法人化学及血清療法研究所 | 外来蛋白質の産生方法 |
US5885827A (en) * | 1996-01-23 | 1999-03-23 | The Regents Of The Universtiy Of California | Eukaryotic high rate mutagenesis system |
US7041870B2 (en) | 2000-11-30 | 2006-05-09 | Medarex, Inc. | Transgenic transchromosomal rodents for making human antibodies |
JP4115281B2 (ja) | 2001-05-11 | 2008-07-09 | キリンファーマ株式会社 | ヒト抗体λ軽鎖遺伝子を含むヒト人工染色体、および子孫伝達可能な該ヒト人工染色体を含む非ヒト動物 |
PT2314629E (pt) | 2002-07-18 | 2014-01-22 | Merus B V | Produção recombinante de misturas de anticorpos |
USRE47770E1 (en) | 2002-07-18 | 2019-12-17 | Merus N.V. | Recombinant production of mixtures of antibodies |
JP4739763B2 (ja) | 2002-12-16 | 2011-08-03 | ゲンマブ エー/エス | インターロイキン8(il−8)に対するヒトモノクローナル抗体 |
AU2002953381A0 (en) * | 2002-12-18 | 2003-01-09 | Diatech Pty Ltd | In vivo affinity maturation scheme |
US20100069614A1 (en) | 2008-06-27 | 2010-03-18 | Merus B.V. | Antibody producing non-human mammals |
EP2395017A3 (de) | 2003-05-30 | 2012-12-19 | Merus B.V. | Entwurf und Verwendung von gepaarten unterschiedlichen Regionen von spezifisch bindenden Molekülen |
CA2619695A1 (en) | 2005-08-18 | 2007-02-22 | Genmab A/S | Therapy with cd4 binding peptides and radiation |
JP5514539B2 (ja) | 2006-03-31 | 2014-06-04 | メダレックス・リミテッド・ライアビリティ・カンパニー | ヒト抗体の調製に用いるためのキメラ抗体を発現するトランスジェニック動物 |
CA2729095C (en) | 2008-06-27 | 2018-12-04 | Merus B.V. | Method for producing a transgenic murine mammal |
MX360109B (es) | 2012-04-20 | 2018-10-23 | Merus Nv | Metodos y medios para la produccion de moleculas de tipo ig. |
EP3737696A1 (de) | 2018-01-12 | 2020-11-18 | Bristol-Myers Squibb Company | Kombinationstherapie mit anti-il-8-antikörpern und anti-pd-1-antikörpern zur behandlung von krebs |
-
1989
- 1989-04-22 GB GB898909218A patent/GB8909218D0/en active Pending
-
1990
- 1990-04-20 AU AU54438/90A patent/AU5443890A/en not_active Abandoned
- 1990-04-20 US US07/768,437 patent/US5371009A/en not_active Expired - Fee Related
- 1990-04-20 JP JP02506357A patent/JP3102697B2/ja not_active Expired - Fee Related
- 1990-04-20 WO PCT/GB1990/000604 patent/WO1990012878A1/en active IP Right Grant
- 1990-04-20 DE DE69022046T patent/DE69022046T2/de not_active Expired - Fee Related
- 1990-04-20 EP EP90906306A patent/EP0469025B1/de not_active Expired - Lifetime
- 1990-04-20 AT AT90906306T patent/ATE127155T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE127155T1 (de) | 1995-09-15 |
JPH04504658A (ja) | 1992-08-20 |
US5371009A (en) | 1994-12-06 |
GB8909218D0 (en) | 1989-06-07 |
JP3102697B2 (ja) | 2000-10-23 |
DE69022046T2 (de) | 1996-02-29 |
EP0469025A1 (de) | 1992-02-05 |
WO1990012878A1 (en) | 1990-11-01 |
EP0469025B1 (de) | 1995-08-30 |
AU5443890A (en) | 1990-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69022046D1 (de) | Verbesserungen im stimulierungsmittelbereich. | |
Todaro et al. | Growth factors produced by sarcoma virus-transformed cells | |
NO880863L (no) | Humant erytropoietingen: hoey ekspresjon i stabilt transfekterte pattedyrceller. | |
JP2016106137A (ja) | 免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法 | |
Stall et al. | Rearrangement and expression of endogenous immunoglobulin genes occur in many murine B cells expressing transgenic membrane IgM. | |
KR900700592A (ko) | 용해성 티-4 유도체 | |
DE68928069D1 (de) | Anti-T-Zell Rezeptordeterminanten zur Behandlung von Autoimmunkrankheiten | |
ATE76878T1 (de) | Solubilisierung von protein-aggregaten. | |
ATE27000T1 (de) | Expression von polypeptiden in hefen. | |
EP0434713A4 (en) | Hiv-1 envelope muteins lacking hypervariable domains | |
Lin et al. | Assignment of the murine interferon sensitivity and cytoplasmic superoxide dismutase genes to chromosome 16 | |
ATE391175T1 (de) | Multidrug resistenz gen | |
ATE93272T1 (de) | Expression von protein c. | |
TR199800912T2 (xx) | T�m�r a��s� ve a��n�n haz�rlanmas� i�in usul. | |
SE9201966D0 (sv) | Interleukin-1beta deletion mutant | |
KR890005267A (ko) | 변형된 플라스미노겐 활성제 | |
DK0430635T3 (da) | Bakterialt collagenasegen | |
WO1997014808A3 (en) | Herpesvirus vectors and their uses | |
Åsjö et al. | Influence of genotype and the organ of origin on the subtype of T-cell in Moloney lymphomas induced by transfer of preleukemic cells from athymic and thymus-bearing mice | |
HU9500619D0 (en) | Cloning and expression of b-app-c100 receptor | |
Lovec et al. | Assignment of FGF13 to human chromosome band Xq21 by in situ hybridization | |
DK82391A (da) | Ekspression og bearbejdning i gaer af autentiske humane fibroblastvaekstfaktorer | |
Sved et al. | Male recombination is not induced in Drosophila melanogaster by extracts of strains with male recombination potential | |
ATE90386T1 (de) | Verfahren zur expression von genen in hefe, dns- fragmente und plasmide die letztere fragmente enthalten und zur durchfuehrung des verfahrens verwendet werden. | |
Vilde | On the adaption of the photosynthesis of the arctic mosses to their habitats. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |